Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy
NEW YORK & BRISBANE, Calif.--(BUSINESS WIRE)--Dec 12, 2021--
More from Central Arizona
AZ Daily Sun | State
NASCAR driver Daniel Surez talks contract extension, new child and love of visiting Phoenix schools
Central Arizona
•
3h ago
Pantagraph | Bloomington
ACLU billboards aim to reach voters beyond its membership
Central Arizona
•
5h ago
Pantagraph | Bloomington
Bloomington man accused of beating woman at her home
Central Arizona
•
5h ago
Pantagraph | Bloomington
Will Arch Manning be benched? Another brutal loss has Steve Sarkisian 'evaluating everything.'
Central Arizona
•
5h ago
Pantagraph | Bloomington
Photos: Undefeated rivals Normal West, Normal Community clash for Big 12 title
Central Arizona
•
5h ago
Pantagraph | Bloomington
IHSA football playoff pairings and schedule for all eight classes
Central Arizona
•
5h ago
Arizona Herald
Jesse Love wins at Phoenix, takes charge in points standings
Central Arizona
•
6h ago